Related Experiment Video

Updated: May 28, 2026

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer
09:40

Tropomodulin 3 Overexpression as a Marker for Platinum Resistance and Immune Infiltration in Ovarian Cancer

Published on: August 2, 2024

Platinum resistance in breast and ovarian cancer cell lines

Niels Eckstein1

  • 1Federal Institute for Drugs and Medical Devices, Kurt-Georg-Kiesinger-Allee 3, 53175 Bonn, Germany. Niels.Eckstein@bfarm.de

Journal of Experimental & Clinical Cancer Research : CR
|October 5, 2011
PubMed

Insights

This review highlights recent advancements in understanding platinum resistance in breast and ovarian cancers. Addressing this challenge is crucial for improving patient survival rates in these deadly diseases.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Breast and ovarian cancers are leading causes of female mortality.
  • Ovarian cancer, though less common than breast cancer, has a lower survival rate, making it the deadliest gynecological neoplasm.
  • Platinum-based chemotherapy is a primary treatment for ovarian cancer and shows promise for triple-negative breast cancer.

Purpose of the Study:

  • To review recent findings on platinum resistance in breast and ovarian cancers.
  • To explore the emergence of resistant phenotypes as a significant obstacle in cancer therapy.

Main Methods:

  • Literature review focusing on research from the past decade.
  • Analysis of studies investigating platinum resistance mechanisms.

Main Results:

  • Platinum-complexes are a long-standing first-line treatment for ovarian cancer.
  • Emergence of platinum-resistant phenotypes is a critical challenge in achieving curative cancer therapy.

Conclusions:

  • Understanding and overcoming platinum resistance is essential for improving treatment outcomes.
  • Continued research into resistance mechanisms is vital for advancing cancer therapy.

More Related Videos

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines11:50

Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines

Published on: September 10, 2014

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...